White Spot Syndrome Virus: Researchers Identify VP53B as a Key Infectivity Factor

The White Spot Syndrome Virus (WSSV) remains a persistent and significant threat to the global shrimp aquaculture industry. However, its complex pathogenic mechanisms remain only partially understood by the scientific community. Recent research has now identified the envelope structural protein VP53B as a critical determinant of oral infection in species like the whiteleg shrimp and crayfish. Specifically, this study reveals how the virus bypasses host defenses to establish systemic infection.

Researchers investigated the functional role of VP53B using a combination of infection bioassays, protein structure prediction, and protease inhibition assays. Consequently, they discovered that VP53B acts directly as a trypsin inhibitor. Notably, the protein also interacts with host hemocyanin. Because of these interactions, the virus effectively disrupts the host's prophenoloxidase-activating system. This disruption weakens a key innate immune pathway and allows the virus to replicate successfully.

Therapeutic Potential Against White Spot Syndrome Virus

Furthermore, the study highlights that VP53B is essential for the per os (oral) route of infection. In India, where shrimp farming is a cornerstone of the coastal economy, these molecular insights are highly valuable for developing biosecurity strategies. Therefore, targeting the VP53B protein could lead to the development of effective therapeutic interventions. Ultimately, these findings provide a roadmap for future research into neutralizing viral envelope proteins to protect aquatic livestock.

Frequently Asked Questions

What is the role of VP53B in WSSV infection?

VP53B is an envelope structural protein that acts as a trypsin inhibitor. It interacts with host hemocyanin to disrupt the shrimp\'s innate immune response, specifically the prophenoloxidase-activating system.

Does the White Spot Syndrome Virus affect human health?

No, the virus is not zoonotic. It is not a threat to human health or food safety, as it specifically targets decapod crustaceans like shrimp, crabs, and lobsters.

Why is this research important for aquaculture?

Since no effective treatments currently exist for WSSV, identifying VP53B as a critical infectivity factor allows scientists to develop targeted therapies and vaccines to prevent massive crop losses.

Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical or veterinary advice. Refer to the latest local and national guidelines for clinical practice.

References

Xia W et al. White Spot Syndrome Virus Envelope Protein VP53B Functions as a Trypsin Inhibitor and Interacts With Hemocyanin. J Fish Dis. 2026 Apr 12. doi: 10.1111/jfd.70183. PMID: 41966821.

Sanchez-Paz A. White spot syndrome virus: an overview on an emergent concern. Vet Res. 2010;41(6):43. doi: 10.1051/vetres/2010015.

World Organisation for Animal Health (WOAH). Infection with white spot syndrome virus. Aquatic Manual. 2023.